Structured evidence table for Moringa Supplementation Blood Glucose Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Moringa Supplementation Blood Glucose Randomized Trial | No systematic research critically evaluated its impact on cardiometabolic outcomes assessed through randomized controlled trials (RCTs), thus this study aimed to do so by synthesizing existing evidence. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Supplementation Blood Glucose Randomized Trial | Random-effects meta-analyses were performed using standardized mean differences, risk of bias was assessed using the Cochrane RoB 2 tool, while the certainty of evidence was evaluated using GRADE assessment. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Supplementation Blood Glucose Randomized Trial | Subgroup analyses suggested potential benefits at doses I 2 frequently >80% for anthropometric and lipid parameters), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Supplementation Blood Glucose Randomized Trial | is traditionally used in African and Asian medicine for its nutritional and therapeutic properties. | 1 | Crișan D (2025) | Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. |
| Moringa Supplementation Blood Glucose Randomized Trial | Evidence from human studies indicates consistent improvements in immune function, glycemic control, and antioxidant status, particularly among individuals with HIV infection, prediabetes, and malnutrition. | 4 | Sianipar EA (2026) | Moringa oleifera Lamk. as a Promising Adjunct Therapeutic Candidate: A Narrative Review of Human Studies and Published Case Reports. |
| Moringa Supplementation Blood Glucose Randomized Trial | a highly valued multipurpose plant, has gained increasing attention owing to its diverse pharmacological properties, including immunomodulatory, antioxidant, and antidiabetic effects. | 4 | Sianipar EA (2026) | Moringa oleifera Lamk. as a Promising Adjunct Therapeutic Candidate: A Narrative Review of Human Studies and Published Case Reports. |
| Moringa Supplementation Blood Glucose Randomized Trial | This narrative review evaluates published human studies and case reports from 2015 to 2025 to assess the efficacy and safety of M. | 4 | Sianipar EA (2026) | Moringa oleifera Lamk. as a Promising Adjunct Therapeutic Candidate: A Narrative Review of Human Studies and Published Case Reports. |
Source documents